Long-term benefit to pallidal deep brain stimulation in a case of dystonia secondary to pantothenate kinase-associated neurodegeneration

Martin Krause*, Wolfgang Fogel, Volker Tronnier, Sabine Pohle, Konstanze Hörtnagel, Ute Thyen, Jens Volkmann

*Corresponding author for this work
62 Citations (Scopus)

Abstract

Pantothenate kinase-associated neurodegeneration (PKAN) is a rare autosomal recessive disorder with onset in childhood and rapid progression. There is no causative and insufficient symptomatic drug therapy. Deep brain stimulation (DBS) of the internal pallidum (GPi) has been reported to improve motor function. Most case reports, however, are limited to short observational periods. The impact of DBS on the progression and life expectancy in PKAN is unknown. We present a 5-year outcome and video documentation of bilateral GPi-DBS of an adolescent patient suffering from genetically defined PKAN.

Original languageEnglish
JournalMovement Disorders
Volume21
Issue number12
Pages (from-to)2255-2257
Number of pages3
ISSN0885-3185
DOIs
Publication statusPublished - 12.2006

Research Areas and Centers

  • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)

Fingerprint

Dive into the research topics of 'Long-term benefit to pallidal deep brain stimulation in a case of dystonia secondary to pantothenate kinase-associated neurodegeneration'. Together they form a unique fingerprint.

Cite this